Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NEXUSSURGL.BOthis companyNexus Surgical and Medicare Limited	₹24.45	11.87×	4.86×	1.11×	8.55×	980.3%	64.8%	12.2%	9.4%	40.9%	39.7%	2.0%	0×	-0.52×	0×	1.96×	0.0%	4	7.52	2	C+
COLINZ.BOColinz Laboratories Limited	₹70.00	21.81×	1.12×	1.83×	7.57×	-17.6%	25.6%	4.1%	8.4%	5.1%	1.8%	28.8%	0.04×	-19.97×	5.39×	3.93×	0.0%	4	7.16	5	S-
DECIPHER.BODecipher Labs Ltd.	₹5.60	-1.71×	0.26×	0.38×	-1.49×	-90.6%	95.4%	-27.8%	-21.9%	-14.9%	-15.4%	-44.0%	0.02×	0.07×	0×	5.22×	0.0%	3	—	2	C
DLCL.BODr. Lalchandani Labs Ltd.	₹6.47	93.8×	0.43×	1.46×	5.92×	658.4%	59.7%	-11.9%	1.5%	0.4%	-2.0%	-17.9%	0.15×	-3.04×	-28.75×	3.79×	0.0%	3	1.33	2	B-
EVOQ.BOEvoq Remedies Ltd.	₹1.60	-25.2×	0.14×	0.24×	-30.58×	-7336.2%	0.1%	-5.9%	-0.9%	-0.5%	-3.2%	-4.7%	0×	-0.34×	0×	6.77×	0.0%	3	1.82	2	B-
KOBO.BOKobo Biotech Ltd.	₹3.56	-1.92×	-0.07×	0×	-173.79×	-1982.9%	0.0%	0.0%	0.0%	3.7%	-2.1%	2.1%	-1.05×	-162.73×	-2,480×	0.23×	0.0%	3	—	—	—
Peer median	—	-1.71×	0.26×	0.38×	-1.49×	-90.6%	25.6%	-5.9%	0.0%	0.4%	-2.1%	-4.7%	0.02×	-3.04×	0×	3.93×	0.0%	3	1.82	2	—